Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Although information about the efficacy and safety experience with caspofungin at 50 mg/m(2) daily is available for children and adolescents, the dosing regimen in infants and toddlers 3 to 24 months of age has yet to be established. We studied the pharmacokinetics and safety of caspofungin at 50 mg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Neely, Michael, Jafri, Hasan S., Seibel, Nita, Knapp, Katherine, Adamson, Peter C., Bradshaw, Susan K., Strohmaier, Kim M., Sun, Peng, Bi, Sheng, Dockendorf, Marissa Fallon, Stone, Julie A., Kartsonis, Nicholas A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2009
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2663098/
https://ncbi.nlm.nih.gov/pubmed/19114680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01027-08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados